Atlas Trials

Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases

Clinical trial NCT07258147 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07258147
Sponsor
Sichuan University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Lung Cancer (SCLC)
Start date
2026-10-31
Primary completion
2027-12-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.